| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.0091 | 0.8 |